Enterprise Europe Network

An innovative French manufacturer, highly specialized in ultrasonic technologies, is looking for new partnerships for R&D co-developments medical projects with companies and scientific research organizations, at European and International scale.

Country of origin:
Country: 
FRANCE
Opportunity:
External Id: 
TOFR20200224001
Published
24/02/2020
Last update
08/04/2020
Expiration date
09/04/2021

Keywords

Partner keyword: 
Medical Research
Medical Technology / Biomedical Engineering
Other therapeutic (including defibrillators)
Electromedical and medical equipment
Engineering activities and related technical consultancy
EXPRESS YOUR INTEREST

Summary

Summary: 
An innovative French manufacturer specialized in ultrasonic technologies is looking for establishing new partnerships and R&D co-development projects with companies and scientific research organizations/universities in the Health sector. It wants to collaborate with inventors and companies, eager to work together on innovative non-invasive therapeutic concepts, directly connected to the human health, well-being and comfort, under technological cooperation or R&D projects agreements.

Description

Description: 

The company is an innovative French manufacturer - leader in its field and with 35 years of experience in the field of innovative ultrasonic solutions.

The core business of this company is to innovate, conceive, produce and market modules and ultrasonic compounds especially dedicated to industrial and health applications. In this perspective, the company has built a very specific technology and positioning for the ultrasonic market.

The team comprises over half of engineers and technicians highly qualified and trained in electronic / IT development fields and ultrasonic technologies. The products use the same technological basis which is the result of several years of research and development. Patented in more than 30 countries, this technology has conquered a large part of their customers for their current product lines.

In 2019 the company has launched its own business unit dedicated to medical applications exclusively – result of several years of analysis and reflection. This business unit has a strong willing to contribute to the development of non-invasive therapeutic techniques generally speaking, by using the ultrasounds.

The scopes of application are significant and will allow to provide concrete solutions to the human well-being and public health. The company promotes the therapeutic ultrasounds as a way to definitely replace and avoid the traditional surgery in certain cases ; extremely expensive and leading sometimes to significant side effects with (very) long recovery period. What is more, the scopes of application are extremely large, as directly connected to the public health issues

The company is looking for establishing new academic and industrial partnerships, in the context of R&D co-development projects, especially with key players acting in biotech and/or medtech sectors generally speaking. The company is opened to all countries (European and international players) and different kinds of cooperation : direct Technological / R&D cooperation agreements or R&D EU projects cooperation agreements (the company does also regularly take part to European and national research programs).

Advantages & innovations

Cooperation plus value: 
- The company is an innovative French manufacturer and leader in its field thanks to our 35 years of expertise and know-how in innovative ultrasonic technologies (the company manages the full value chain). - Its technology is recognized and patented in 30 countries (20 patents). Its success has been conceivable thanks to its expert team, mainly composed of engineers and technicians highly qualified and trained. - The innovation – generally speaking – is part of its core priorities and commitments. The company has a team of experts and engineers, which have this strong willing to contribute to the human health, well-being and comfort. And for reaching this purpose, the company encourages non-invasive therapeutic techniques (vs the traditional surgery). - The company manages the full value chain (from the research, conception, development, production and marketing steps). - It is mainly focused on innovative therapeutic concepts (they are not dedicated to the diagnostic industry). The scopes of application are extremely various and plentiful. - The company has developed a very specific technology and positioning on the ultrasound market. Its technology allows a significant cut in development/integration costs and a real “time to market” acceleration. Details about the technology proposed will be released after signature of an non disclosure agreement with the partner. - It is resolutely focused on overseas market. - The company is planning to multiply per 3 its production capacity to face the development of their activity. - It regularly takes part to European cooperation and funding programs.

Stage of development

Cooperation stage dev stage: 
Under development/lab tested

Partner sought

Cooperation area: 
Type of partner sought : scientific research organization, laboratory, university, SME or huge company, start-up with a medtech and/or biotech profile and a strong R&D activity. Role ; The partner must want to conceive innovative therapeutic concepts (not diagnostic) with the french company, in the filed of oncology for example. These concepts should be directly connected to the human health and well-being (the scopes of application are extremely numerous and large – the company can discuss about these following points under a non disclosure agreement). The partner must have a complementary profile. The partnerships will take the form of technical cooperation agreements or research cooperation agreements.

Type and size

Cooperation task: 
SME 11-50,University,R&D Institution,SME <10,>500 MNE,251-500,SME 51-250,>500